Neuberger Berman Group
AMED

Neuberger Berman Group’s Amedisys AMED Stock Holding History

Neuberger Berman Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-270,324
Closed -$26.6M – 2037
2025
Q2 		$26.6M Buy
+270,324
New +$25.6M 0.02% 574
2022
Q4 		– Sell
-31,140
Closed -$3.01M – 1791
2022
Q3 		$3.01M Sell
31,140
-260
-0.8% -$31K ﹤0.01% 996
2022
Q2 		$3.3M Buy
31,400
+1,257
+4% +$161K ﹤0.01% 1004
2022
Q1 		$5.19M Buy
30,143
+3,501
+13% +$523K ﹤0.01% 952
2021
Q4 		$4.25M Buy
26,642
+578
+2% +$92.9K ﹤0.01% 1018
2021
Q3 		$3.83M Buy
26,064
+221
+0.9% +$45.9K ﹤0.01% 1018
2021
Q2 		$6.29M Buy
25,843
+4,872
+23% +$1.28M 0.01% 909
2021
Q1 		$5.51M Buy
20,971
+5,908
+39% +$1.67M 0.01% 933
2020
Q4 		$4.42M Buy
15,063
+1,202
+9% +$308K ﹤0.01% 934
2020
Q3 		$3.28M Sell
13,861
-5
-0% -$1.14K ﹤0.01% 956
2020
Q2 		$2.75M Buy
13,866
+3,805
+38% +$710K ﹤0.01% 948
2020
Q1 		$1.85M Hold
10,061
– – ﹤0.01% 963
2019
Q4 		$1.68M Buy
+10,061
New +$1.5M ﹤0.01% 1068
2019
Q2 		– Sell
-2,421
Closed -$298K – 1548
2019
Q1 		$298K Buy
+2,421
New +$304K ﹤0.01% 1367
2014
Q3 		– Sell
-13,316
Closed -$223K – 1643
2014
Q2 		$223K Hold
13,316
– – ﹤0.01% 1593
2014
Q1 		$198K Buy
+13,316
New +$205K ﹤0.01% 1543

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Neuberger Berman Group's AMED Position: Q3 2025 in Review

Neuberger Berman Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 270,324 shares — an estimated $26.6M sold.

Neuberger Berman Group first reported a position in AMED in Q1 2014 and held it in 16 quarters. The position peaked at $26.6M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Neuberger Berman Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 270,324 Amedisys shares in Q3 2025, an estimated $26.6M.
  • Neuberger Berman Group first reported a position in Amedisys in Q1 2014 and held it in 16 quarters.
  • Neuberger Berman Group's Amedisys position peaked at $26.6M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Neuberger Berman Group's 13F filing for Q3 2025, filed 12 Nov 2025.